Companies › RPRX
ROYALTY PHARMA PLC CLASS A (RPRX)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001802768 · EDGAR filings · Updated 2026-07-02
ROYALTY PHARMA PLC CLASS A (RPRX) has 585 institutional managers reporting positions valued at $16.9B per the latest 13F reporting period. SEC filings include an active material impairment disclosure (8-K Item 2.06).
Latest updates
- 2026-07-02 — Insider transaction reported (Form 4)
- 2026-07-02 — Insider transaction reported (Form 4)
- 2026-07-01 — Notice of proposed sale filed (Form 144)
- 2026-07-01 — Notice of proposed sale filed (Form 144)
- 2026-06-30 — Insider transaction reported (Form 4)
- 2026-06-25 — Insider transaction reported (Form 4)
- 2026-06-25 — Insider transaction reported (Form 4)
- 2026-06-24 — Notice of proposed sale filed (Form 144)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, ROYALTY PHARMA PLC CLASS A has 585 institutional holders.
| # | Institution | Reported value | % of tracked total |
|---|---|---|---|
| 1 | MORGAN STANLEY | $2.09B | 12.3% |
| 2 | Capital International Investors | $1.68B | 9.9% |
| 3 | BlackRock, Inc. | $1.24B | 7.3% |
| 4 | FMR LLC | $1.21B | 7.1% |
| 5 | BAILLIE GIFFORD & CO | $775.0M | 4.6% |
| 6 | Swedbank AB | $555.8M | 3.3% |
| 7 | STATE STREET CORP | $527.2M | 3.1% |
| 8 | Capital World Investors | $385.5M | 2.3% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | $376.5M | 2.2% |
| 10 | ADAGE CAPITAL PARTNERS GP, L.L.C. | $358.8M | 2.1% |
Full holder history and quarter-over-quarter changes are available inside the app.
Insider activity
Insiders reported 94 transactions (0 buys, 52 sells) across 15 reporting insiders, with a net reported value of −$56.1M.
Quarterly net insider value, as reported in Form 4 filings.
Data flags from SEC filings
Debt maturity schedule
Principal coming due by year for ROYALTY PHARMA PLC CLASS A, from the company's own SEC prospectus filings (424B) tracked by Sightfile.
| Year | Bond series maturing | Known principal due |
|---|---|---|
| 2027 | 1 | — |
| 2029 | 1 | — |
| 2030 | 1 | — |
| 2031 | 2 | — |
| 2034 | 1 | — |
| 2035 | 1 | — |
| 2040 | 1 | — |
| 2050 | 1 | — |
| 2051 | 1 | — |
| 2054 | 1 | — |
| 2055 | 1 | — |
Coupons, seniority and prospectus links for each series are available inside the app.
Related companies
INCYTE CORP (INCY) · ZIMMER BIOMET HLDGS INC (ZBH) · ALCON AG (ALC) · MODERNA INC (MRNA) · TENET HEALTHCARE CORP (THC) · ROIVANT SCIENCES LTD (ROIV)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-02.